We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.04B
AUM Growth
+$368M
Cap. Flow
+$68.3M
Cap. Flow %
1.69%
Top 10 Hldgs %
14.84%
Holding
1,360
New
108
Increased
584
Reduced
484
Closed
87

Sector Composition

Rank Sector Weight
1 Technology 14.01%
2 Healthcare 12.17%
3 Financials 11.3%
4 Consumer Discretionary 8.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNDT
476
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1.57M 0.04%
94,800
-23,760
-20% -$381K
VEEV icon
477
Veeva Systems
VEEV
$38.3B
$1.57M 0.04%
11,136
-1,948
-15% -$286K
XEL icon
478
Xcel Energy
XEL
$47.9B
$1.55M 0.04%
24,453
+1,798
+8% +$112K
ITM icon
479
VanEck Intermediate Muni ETF
ITM
$2.13B
$1.54M 0.04%
30,729
+2,039
+7% +$102K
IAU icon
480
iShares Gold Trust
IAU
$64.6B
$1.54M 0.04%
52,984
-98,949
-65% -$2.81M
RY icon
481
Royal Bank of Canada
RY
$294B
$1.53M 0.04%
19,363
-2,581
-12% -$208K
P
482
Everpure Inc
P
$32.9B
$1.53M 0.04%
89,550
+35,000
+64% +$619K
TDG icon
483
TransDigm Group
TDG
$67.4B
$1.53M 0.04%
2,734
+215
+9% +$118K
GBIL icon
484
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.59B
$1.53M 0.04%
15,264
+8,849
+138% +$888K
SLB icon
485
SLB Ltd
SLB
$77.9B
$1.53M 0.04%
37,981
-10,928
-22% -$390K
VAR
486
DELISTED
Varian Medical Systems, Inc.
VAR
$1.52M 0.04%
10,725
+200
+2% +$25.5K
PDI icon
487
PIMCO Dynamic Income Fund
PDI
$7.45B
$1.52M 0.04%
46,859
+10,136
+28% +$334K
PFPT
488
DELISTED
Proofpoint, Inc.
PFPT
$1.52M 0.04%
13,217
+11,326
+599% +$1.35M
AGN
489
DELISTED
Allergan plc
AGN
$1.51M 0.04%
7,892
-588
-7% -$106K
IVE icon
490
iShares S&P 500 Value ETF
IVE
$49.9B
$1.5M 0.04%
11,549
+286
+3% +$35.6K
VSS icon
491
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$1.5M 0.04%
13,501
-3,059
-18% -$327K
SJNK icon
492
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.79B
$1.5M 0.04%
55,545
+2,730
+5% +$73.1K
SPHD icon
493
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.38B
$1.49M 0.04%
33,898
+1,286
+4% +$55.1K
JKHY icon
494
Jack Henry & Associates
JKHY
$11B
$1.49M 0.04%
10,214
+565
+6% +$82.5K
PEY icon
495
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.16B
$1.48M 0.04%
77,712
-304
-0.4% -$5.59K
GPC icon
496
Genuine Parts
GPC
$18.5B
$1.47M 0.04%
13,880
-126
-0.9% -$13K
BSV icon
497
Vanguard Short-Term Bond ETF
BSV
$45.6B
$1.47M 0.04%
18,195
-1,691
-9% -$136K
XLE icon
498
State Street Energy Select Sector SPDR ETF
XLE
$39.1B
$1.46M 0.04%
48,756
+35,548
+269% +$1.05M
NOV icon
499
NOV
NOV
$7.33B
$1.46M 0.04%
58,416
-3,345
-5% -$75.3K
DRE
500
DELISTED
Duke Realty Corp.
DRE
$1.46M 0.04%
42,195
+45
+0.1% +$1.55K

Similar funds

Oppenheimer & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Oppenheimer & Co held 1,360 positions worth $4.04B, up 10% from $3.67B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer & Co's Q4 2019 filing shows 108 new, 584 increased, 484 reduced and 87 closed positions. Its largest new stake was CAE Inc. Common Shares: 78,310 shares worth $2.07M. The largest sale was Celgene Corp, an estimated $6.53M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q4 2019 buy was CAE Inc. Common Shares: 78,310 shares worth $2.07M.
  • Oppenheimer & Co added most to DocuSign in Q4 2019, an estimated $4.67M increase.
  • Oppenheimer & Co's biggest Q4 2019 reduction was Apple, cutting an estimated $5.68M.
  • Oppenheimer & Co fully exited Celgene Corp in Q4 2019, selling an estimated $6.53M.
  • Oppenheimer & Co's ten largest holdings make up 15% of its $4.04B portfolio in Q4 2019.
  • Oppenheimer & Co opened 108 new positions and closed 87 in Q4 2019.
  • Oppenheimer & Co's portfolio value rose 10% quarter-over-quarter to $4.04B.

Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.